| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 2241 |
| 1 | POLYETHYLENE GLYCOL 3350 | 2021 |
| 2 | LENALIDOMIDE | 1159 |
| 3 | OXYCODONE HYDROCHLORIDE | 644 |
| 4 | ETONOGESTREL | 586 |
| 5 | PREDNISONE | 522 |
| 6 | RIVAROXABAN | 466 |
| 7 | ASPIRIN | 432 |
| 8 | METHOTREXATE SODIUM | 410 |
| 9 | CABOZANTINIB | 401 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REZAFUNGIN | 12 | 0.1188 |
| 1 | PRALSETINIB | 194 | 0.1064 |
| 2 | INFLIXIMAB-DYYB | 320 | 0.0929 |
| 3 | OLUTASIDENIB | 23 | 0.0796 |
| 4 | ELINZANETANT | 18 | 0.0447 |
| 5 | LOTILANER OPHTHALMIC SOLUTION | 167 | 0.0426 |
| 6 | FOSTAMATINIB | 316 | 0.0401 |
| 7 | PRAZIQUANTEL | 12 | 0.0396 |
| 8 | HYDROCODONE BITARTRATE AND IBUPROFEN | 18 | 0.0379 |
| 9 | SCOPOLAMINE TRANSDERMAL SYSTEM | 8 | 0.0300 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 2241 |
| 1 | Osmotic Laxative [EPC] | 2190 |
| 2 | Thalidomide Analog [EPC] | 1449 |
| 3 | Corticosteroid [EPC] | 1387 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 977 |
| 5 | Progestin [EPC] | 753 |
| 6 | Benzodiazepine [EPC] | 545 |
| 7 | Factor Xa Inhibitor [EPC] | 540 |
| 8 | Kinase Inhibitor [EPC] | 511 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 465 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ectoparasiticide [EPC] | 167 | 0.0426 |
| 1 | Antithrombin-directed RNA Interaction [EPC] | 1 | 0.0179 |
| 2 | RNA Synthetase Inhibitor Antibacterial [EPC] | 162 | 0.0117 |
| 3 | Semifluorinated Alkane [EPC] | 26 | 0.0112 |
| 4 | Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] | 1 | 0.0096 |
| 5 | Cannabinoid [EPC] | 63 | 0.0078 |
| 6 | Antiparasitic [EPC] | 35 | 0.0077 |
| 7 | Vasopressin V2 Receptor Antagonist [EPC] | 114 | 0.0076 |
| 8 | Pediculicide [EPC] | 35 | 0.0074 |
| 9 | Osmotic Laxative [EPC] | 2190 | 0.0074 |